Category: Cardiac Rhythm Management
FDA regulators grant AliveCor new clearance for an at-home heart rhythm test for diagnosing asymptomatic atrial fibrillation.
AliveCor hit a major turning point for its smartphone-based ECG technology with FDA clearance for a new algorithm that helps patients diagnose their own heart rhythms.
Patients are able to instantly identify atrial fibrillation in real-time ECG recordings.
Researchers report that patients with heart failure that were monitored from afar via fared better than those that received traditional follow-up care.
Home-based heart monitoring could help save lives while reducing the cost of follow-up care for patients with heart failure, according to a new study.
Mirowski Family Ventures asks the U.S. Supreme Court to hear its appeal in a patent infringement lawsuit against Medtronic.
Surgical patients who experience atrial fibrillation may see a doubled stroke risk in the months following their procedure, according to a new study published in JAMA.
Results from a new study suggest that atrial fibrillation (AF) may pose a significant threat to patients undergoing surgery, especially those having non-cardiac procedures.
In an analysis of more than 1.7 million patients, researchers found that perioperative AF was associated with twice the risk of stroke in patients who had non-cardiac surgery. Patients who underwent a cardiac procedure saw a 30% increase in their stroke risk.
Medtech titan Medtronic launched a new cardiac resynchronization therapy-pacemaker for the Indian market after landing CE Mark approval in the European Union earlier this year.
MASSDEVICE ON CALL — Medtronic (NYSE:MDT) this week announced that it's bringing its Viva cardiac resynchronization therapy-pacemaker to the market in India, a country where Medtronic is banking on significant growth.
New system helps physicians deliver cardiac resynchronization therapy optimally and efficiently to heart failure patients.